Hepatitis C Virus NS3 Inhibitors: Current and Future Perspectives

Currently, hepatitis C virus (HCV) infection is considered a serious health-care problem all over the world. A good number of direct-acting antivirals (DAAs) against HCV infection are in clinical progress including NS3-4A protease inhibitors, RNA-dependent RNA polymerase inhibitors, and NS5A inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Salam, Kazi Abdus, Akimitsu, Nobuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825274/
https://www.ncbi.nlm.nih.gov/pubmed/24282816
http://dx.doi.org/10.1155/2013/467869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825274/
https://www.ncbi.nlm.nih.gov/pubmed/24282816
http://dx.doi.org/10.1155/2013/467869

Ejemplares similares